WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
The effect of menopausal hormone therapy (MHT) previously known as hormone replacement therapy on cardiovascular health remains unclear and controversial. This cross-sectional study examined the impact of MHT on left ventricular (LV) and left atrial (LA) structure and function, alterations in which are markers of subclinical cardiovascular disease, in the UK Biobank population-based cohort. In this large cohort of post-menopausal women free of cardiovascular disease, use of MHT was not associated with adverse, subclinical changes in cardiac structure and function. The findings provide a novel way to examine the impact of MHT on the cardiovascular system and future work will focus upon linkage of MHT use and CMR parameters to cardiovascular outcome data.